Published in Proc Soc Exp Biol Med on August 01, 1951
West Nile fever--a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis (1999) 7.50
High-throughput detection of West Nile virus RNA. J Clin Microbiol (2001) 5.77
Hemagglutination with arthropod-borne viruses. J Exp Med (1954) 3.06
West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis (2004) 3.00
Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg Infect Dis (2005) 1.98
Nature of Inherited Resistance to Viruses Affecting the Nervous System. Proc Natl Acad Sci U S A (1952) 1.91
Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol (2010) 1.88
Visualization of Egypt 101 virus in the mouse's brain and in cultured human carcinoma cells by means of fluorescent antibody. J Exp Med (1955) 1.74
Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis (2014) 1.72
Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg Infect Dis (2002) 1.64
The global ecology and epidemiology of West Nile virus. Biomed Res Int (2015) 1.21
Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. I. The virus carrier state and the development of neutralizing antibodies. J Exp Med (1953) 1.17
A review of the epidemiological and clinical aspects of West Nile virus. Int J Gen Med (2014) 1.02
VIRUS BIOGRAPHIES. I. GROWTH OF WEST NILE AND GUAROA VIRUSES IN TISSUE CULTURE. J Bacteriol (1964) 0.98
[Recent data from serological surveys on the prevalence of arbovirus infections in Africa, with special reference to yellow fever]. Bull World Health Organ (1970) 0.94
Isolation of West Nile virus from the brains of children who had died of encephalitis. Bull World Health Organ (1984) 0.93
Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. II. The development of complement-fixing antibodies. J Exp Med (1953) 0.91
Characterization of Rabensburg virus, a flavivirus closely related to West Nile virus of the Japanese encephalitis antigenic group. PLoS One (2012) 0.90
Emergence of west nile virus lineage 2 in europe: a review on the introduction and spread of a mosquito-borne disease. Front Public Health (2014) 0.88
West Nile virus state of the art report of MALWEST Project. Int J Environ Res Public Health (2013) 0.87
Genetically delivered antibody protects against West Nile virus. Antiviral Res (2007) 0.81
Infection with non-lethal West Nile virus Eg101 strain induces immunity that protects mice against the lethal West Nile virus NY99 strain. Viruses (2014) 0.79
Induction of virus-specific effector immune cell response limits virus replication and severe disease in mice infected with non-lethal West Nile virus Eg101 strain. J Neuroinflammation (2015) 0.79
Detection of West Nile virus in wild birds in Tana River and Garissa Counties, Kenya. BMC Infect Dis (2016) 0.79
Identification of host genes leading to West Nile virus encephalitis in mice brain using RNA-seq analysis. Sci Rep (2016) 0.77
West Nile Virus Spreads Transsynaptically within the Pathways of Motor Control: Anatomical and Ultrastructural Mapping of Neuronal Virus Infection in the Primate Central Nervous System. PLoS Negl Trop Dis (2016) 0.76
An outbreak of West Nile Virus infection in the region of Monastir, Tunisia, 2003. Pathog Glob Health (2014) 0.75
TICK-BORNE VIRUSES. A REVIEW OF AN ARTHROPOD-BORNE VIRUS PROBLEM OF GROWING IMPORTANCE IN THE TROPICS. Bull World Health Organ (1963) 0.75
Detection of dengue virus serotypes 1, 2 and 3 in selected regions of Kenya: 2011-2014. Virol J (2016) 0.75
Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence. J Virol (2016) 0.75
Human Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in Vitro and in Vivo. J Antivir Antiretrovir (2009) 0.75
A Comprehensive Review of Common Bacterial, Parasitic and Viral Zoonoses at the Human-Animal Interface in Egypt. Pathogens (2017) 0.75
Plaque formation with poliomyelitis, Coxsackie, and orphan (echo) viruses in bottle cultures of monkey epithelial cells. Virology (1955) 6.68
THE INCORPORATION OF SV40 MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGEN. Proc Natl Acad Sci U S A (1964) 5.88
Intracellular forms of pox viruses as shown by the electron microscope (Vaccinia, Ectromelia, Molluscum Contagiosum). J Exp Med (1953) 5.58
Ohio strains of a virus pathogenic for infant mice, Coxsackie group; simultaneous occurrence with poliomyelitis virus in patients with summer grippe. J Exp Med (1950) 5.57
SYNTHESIS OF SV40 TUMOR ANTIGEN DURING REPLICATION OF SIMIAN PAPOVAVIRUS (SV40). Proc Natl Acad Sci U S A (1964) 5.23
Magnesium chloride enhancement of cell susceptibility to poliovirus. Virology (1962) 4.92
Tissue culture techniques and their application to original isolation, growth, and assay of poliomyelitis and orphan viruses. Ann N Y Acad Sci (1955) 4.90
Disease resembling nonparalytic poliomyelitis associated with a virus pathogenic for infant mice. J Am Med Assoc (1949) 4.58
A method for staining virus particles and identifying their nucleic acid type in the electron microscope. Virology (1962) 4.42
A survey of neutralizing antibodies to poliomyelitis virus in Cairo, Egypt. Am J Hyg (1952) 4.05
Assay of poliomyelitis neutralizing antibody in disposable plastic panels. Bull World Health Organ (1956) 3.98
Factors influencing enterovirus and reovirus growth and plaque formation. Tex Rep Biol Med (1962) 3.85
Suppression of adventitious agents in monkey kidney cultures. Tex Rep Biol Med (1962) 3.84
Papova virus group. Science (1962) 3.82
Coxsackie viruses from sewage; methodology including an evaluation of the grab sample and gauze pad collection procedures. Am J Hyg (1954) 3.71
Studies on the Coxsackie viruses; properties, immunological aspects and distribution in nature. Bull N Y Acad Med (1950) 3.54
INCOMPLETE SIMIAN PAPOVAVIRUS SV40. FORMATION OF NON-INFECTIOUS VIRAL ANTIGEN IN THE PRESENCE OF FLUOROURACIL. J Exp Med (1964) 3.52
Social serology; antibody levels in a normal young population during an epidemic of poliomyelitis. Am J Hyg (1951) 3.39
DIFFERENTIAL EFFECTS OF INHIBITORS ON THE STEPS LEADING TO THE FORMATION OF SV40 TUMOR AND VIRUS ANTIGENS. J Exp Med (1965) 3.36
A virus isolated from patients diagnosed as non-paralytic poliomyelitis or aseptic meningitis. Proc Soc Exp Biol Med (1949) 3.27
Tumorigencity of simian papovavirus SV40 and of virus-transformed cells. J Natl Cancer Inst (1963) 3.23
Comparative neutralizing antibody patterns to Lansing (type 2) poliomyelitis virus in different populations. Am J Hyg (1952) 3.18
In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells. J Exp Med (1959) 2.98
Pathogenesis of coxsackie virus infection; multiplication of virus and evolution of the muscle lesion in mice. J Exp Med (1951) 2.95
VIRUS-INDUCED INTRANUCLEAR ANTIGEN IN CELLS TRANSFORMED BY PAPOVAVIRUS SV40. Proc Soc Exp Biol Med (1965) 2.95
PHOTODYNAMIC INACTIVATION OF POLIOVIRUS. Virology (1963) 2.92
Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J Exp Med (1950) 2.88
The 1961 Middletown Oral Poliovirus Vaccine Program. IX. Isolation of enteroviruses from sewage before and after vaccine administration. Yale J Biol Med (1962) 2.83
Virus-like particles and inclusion bodies in skin papillomas. J Invest Dermatol (1950) 2.81
The histopathology of Coxsackie virus infection in mice. I. Morphologic observations with four different viral types. Am J Pathol (1952) 2.79
Morphologic characteristics of plaques produced on monkey kidney monolayer cultures by enteric viruses (poliomyelitis, Coxsackie, and echo groups. J Immunol (1957) 2.76
The cellular changes produced in tissue cultures by herpes B virus correlated with the concurrent multiplication of the virus. J Exp Med (1955) 2.74
Poliomyelitis viruses in tissue culture. IV. Protein-free nutrient media in stationary and roller tube cultures. Proc Soc Exp Biol Med (1952) 2.69
PAPOVAVIRUS SV40: FAILURE TO ISOLATE INFECTIOUS VIRUS FROM TRANSFORMED HAMSTER CELLS SYNTHESIZING SV40-INDUCED ANTIGENS. Virology (1964) 2.60
Microepidemiology of poliomyelitis and herpes-B infections: spread of the viruses within tissue cultures. J Immunol (1955) 2.59
Effect of sodium bicarbonate concentration on plaque formation of virulent and attenuated polioviruses. J Immunol (1958) 2.57
Sequence of morphological changes in epithelial cell cultures infected with poliovirus. J Exp Med (1956) 2.44
Stabilized suspension of monkey kidney cells suitable for intercontinental shipment. Proc Soc Exp Biol Med (1955) 2.44
Differences in cellular pathogenicity of two immunologically related poliomyelitis viruses as revealed in tissue culture. Proc Soc Exp Biol Med (1951) 2.38
Immunofluorescent, cytochemical, and microcytological studies on the growth of the simian vacuolating virus (SV-40) in tissue culture. Exp Mol Pathol (1962) 2.31
Comparative susceptibility of kidney cells from different monkey species to enteric viruses (poliomyelitis, Coxsackie, and echo groups). J Immunol (1957) 2.24
Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures. Virology (1961) 2.20
Identification of Coxsackie viruses by immunological methods and their classification into 16 antigenically distinct types. J Immunol (1952) 2.15
Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period; the ratio of inapparent infection to clinical poliomyelitis. Am J Hyg (1953) 2.13
IMMUNITY IN HAMSTERS TO CELLS TRANSFORMED IN VITRO AND IN VIVO BY SV40. TESTS FOR ANTIGENIC RELATIONSHIP AMONG THE PAPOVAVIRUSES. J Immunol (1963) 2.11
TUMOR AND VIRUS ANTIGENS OF SIMIAN VIRUS 40: DIFFERENTIAL INHIBITION OF SYNTHESIS BY CYTOSINE ARABINOSIDE. Science (1965) 2.09
A NEW MEMBER OF THE HERPESVIRUS GROUP ISOLATED FROM SOUTH AMERICAN MARMOSETS. J Immunol (1964) 2.07
Antibodies to three different antigenic types of poliomyelitis virus in sera from North Alaskan Eskimos. Am J Hyg (1951) 2.04
Stabilization of poliovirus by cations. Tex Rep Biol Med (1961) 2.02
Infection of laboratory workers with coxsackie viruses. Ann Intern Med (1950) 1.99
Poliomyelitis virus in tissue culture. VI. Use of kidney epithelium grown on glass. Proc Soc Exp Biol Med (1953) 1.96
The degree and duration of poliomyelitis virus excretion among vaccinated household contacts of clinical cases of poliomyelitis. Pediatrics (1958) 1.96
The natural history of West Nile Fever. I. Clinical observations during an epidemic in Israel. Am J Hyg (1956) 1.95
Association of mouse pathogenic strain of Echo virus type 9 with aseptic meningitis. Proc Soc Exp Biol Med (1957) 1.86
A MORPHOLOGIC COMPARISON BETWEEN THE DEVELOPMENTAL STAGES OF HERPES ZOSTER AND HUMAN CYTOMEGALOVIRUS. Exp Mol Pathol (1965) 1.83
Immunological reactions of the Coxsackie viruses. II. The complement fixation test. J Exp Med (1950) 1.82
Antigenic crossings with in poliovirus types. Proc Soc Exp Biol Med (1955) 1.79
The specificity of the complement fixation test in poliomyelitis. Yale J Biol Med (1954) 1.79
Complete and coreless forms of reovirus (ECHO 10). Ratio of number of virus particles to infective units in the one-step growth cycle. Virology (1961) 1.78
An endemiological study of enteric virus infections: poliomyelitis, coxsackie, and orphan (ECHO) viruses isolated from normal children in two socioeconomic groups. J Exp Med (1956) 1.75
Isolation of B virus (herpes group) from the central nervous system of a rhesus monkey. J Exp Med (1954) 1.73
Electron microscopy of viruses of human papilloma, molluscum contagiosum, and vaccinia, including observations on the formation of virus within the cell. Ann N Y Acad Sci (1952) 1.73
IRREVERSIBLE PHOTOSENSITIZATION OF VIRUSES. Virology (1964) 1.72
Association of echo virus type 6 with aseptic meningitis. Proc Soc Exp Biol Med (1957) 1.72
Endemic and epidemic trends of poliomyelitis in Central and South America. Bull World Health Organ (1958) 1.72
Immunization of preschool children with oral poliovirus vaccine (Sabin). JAMA (1961) 1.67
Electron microscopic counting of virus particles by sedimentation on aluminized grids. J Immunol (1962) 1.66
COXSACKIE VIRUS B3 MYOCARDITIS IN MICE. AN ELECTRON MICROSCOPIC, IMMUNOFLUORESCENT AND VIRUS-ASSAY STUDY. Am J Pathol (1964) 1.64
Effect of milk and cream on the thermal inactivation of human poliomyelitis virus. Am J Public Health Nations Health (1952) 1.62
Poliomyelitis viruses in tissue culture. V. Reaction of virus and antibody; variables of the quantitative neutralization test. Am J Hyg (1953) 1.61
West Nile fever; the clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases. Am J Hyg (1954) 1.61
Observations on serological epidemiology antibodies to the Lansing strain of poliomyelitis virus in sera from Alaskan eskimos. Am J Hyg (1950) 1.57
A survey of poliomyelitis virus antibodies in French Morocco. Am J Trop Med Hyg (1955) 1.55
Effect of cations on thermal inactivation of vaccinia, herpes simplex, and adenoviruses. J Immunol (1962) 1.55
ADENOVIRUS-SV40 "HYBRIDS": PLAQUE PURIFICATION INTO LINES IN WHICH THE DETERMINANT FOR THE SV40 TUMOR ANTIGEN IS LOST OR RETAINED. Virology (1965) 1.54
Orphan viruses of man and animals. Ann N Y Acad Sci (1958) 1.49
Factors influencing the proliferation of viruses. Tex Rep Biol Med (1957) 1.48
Rapid development of drug-resistant mutants of poliovirus. Science (1961) 1.47
The detection of poliovirus and other enteric viruses in flies. Results of tests carried out during an oral poliovirus vaccine trial. Am J Hyg (1961) 1.47
The size of Coxsackie viruses and Lansing poliomyelitis virus determined by sedimentation and ultra filtration. J Immunol (1951) 1.45
Seasonal distribution of Coxsackie viruses in urban sewage and flies. Am J Hyg (1954) 1.44
Multiplication of poliomyelitis viruses in tissue cultures of monkey testes. II. Direct isolation and typing of strains from human stools and spinal cords in roller tubes. Am J Hyg (1952) 1.44
Application of tissue culture methods to epidemiological studies of poliomyelitis. Am J Public Health Nations Health (1954) 1.42
The trial use of Sabin's attenuated type 1 poliovirus vaccine in a village in southern Arizina. Am J Hyg (1959) 1.42
Infection induced by oral administration of attenuated poliovirus to persons possessing homotypic antibody. J Exp Med (1957) 1.42